Trademark Overview
On Wednesday, June 17, 2026, a trademark application was filed for NAKU with the United States Patent and Trademark Office. The USPTO has given the NAKU trademark a serial number of 99889749. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, June 17, 2026. This trademark is owned by Ferring B.V.. The NAKU trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Biological preparations for use in the pharmaceutical industry; biological preparations for scientific and research use; biological cell preparations for use in the pharmaceutical industry and for laboratory and scientific use; T-cells and gamma delta T-cells for use in the pharmaceutical industry and for laboratory and scientific use; cell cultures for use in the pharmaceutical industry and for laboratory and scientific use; biological materials for use in cellular engineering; biological materials for use in immunology research; cellular starting materials for use in the pharmaceutical industry and for laboratory and scientific use; biological preparations for use in the development of cellular therapies; biological materials for use in pharmaceutical and biomedical research
Pharmaceutical and biological preparations for medical and therapeutic use; cellular preparations for medical and therapeutic use; T-cells and gamma delta T-cells for medical and therapeutic use; genetically engineered cellular preparations for medical and therapeutic use; engineered immune cell preparations for medical and therapeutic purposes; biological preparations for use in cellular therapy; cell-based therapeutic preparations; cellular therapeutic preparations for the treatment of cancer, infectious diseases and immune-related disorders
Pharmaceutical and biomedical research and development services; scientific research and development in the field of biotechnology, immunology, cell therapy, immunotherapy and regenerative medicine; scientific research relating to immune cells, T-cells, gamma delta T-cells, adoptive cell therapies and cancer therapies; laboratory research relating to cellular and genetic engineering; development of engineered immune cells and cellular therapeutic products for therapeutic applications; laboratory services relating to biotechnology and cellular manipulation; clinical research services; scientific consultancy relating to biotechnology, immunotherapy and pharmaceutical development; providing scientific information relating to cellular therapies and immunotherapeutics